Picture of Virbac SA logo

VIRP — Virbac SA News Story

0.000.00%
fr flag iconLast trade - 00:00
HealthcareBalancedMid CapHigh Flyer

French and Benelux stocks-Factors to watch

Sept 16 (Reuters) - Below are company-related news and
stories from France and Benelux which could have an impact on
the region's markets or individual stocks.
    
    REXEL  RXL.PA :
    QXO  QXO.O , the company billionaire Brad Jacobs is seeking
to launch into building services, recently made an offer of
around $9.4 billion to acquire Rexel  RXL.PA  that the French
company on Sunday said it had rebuffed.
 
    SANOFI  SASY.PA :
    Sanofi and Regeneron have received another regulatory
approval from the U.S. FDA for their Dupixent product.  

    VIRBAC  VIRB.PA :
    The veterinarian pharmaceutical firm posted an adjusted
current operating income of and confirmed its full-year target. 

Pan-European market data:
European Equities speed guide................... EUR/EQUITY 
FTSE Eurotop 300 index.............................. .FTEU3 
DJ STOXX index...................................... .STOXX 
Top 10 STOXX sectors........................... .PGL.STOXXS 
Top 10 EUROSTOXX sectors...................... .PGL.STOXXES 
Top 10 Eurotop 300 sectors..................... .PGL.FTEU3S 
Top 25 European pct gainers....................... .PG.PEUR 
Top 25 European pct losers........................ .PL.PEUR 

Main stock markets:
Dow Jones............... .DJI   Wall Street report ..... .N 
Nikkei 225............. .N225   Tokyo report............ .T 
FTSE 100............... .FTSE   London report........... .L 
Xetra DAX............. .GDAXI   Frankfurt items......... .F 
CAC-40................. .FCHI   Paris items............ .PA 
World Indices..................................... 0#.INDEX 
Reuters survey of world bourse outlook......... EQUITYPOLL1 
European Asset Allocation........................ EUR/ASSET 

Reuters News at a glance:
Top News............. TOP/NEWS 
Equities.............. TOP/EQE 
Main oil report........... O/R 
Main currency report..... FRX/ 

 ((Gdansk Newsroom: +48 58 769 66 00;
Paris Equities: +33 1 49 49 54 52))

Recent news on Virbac SA

See all news